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Schizophrenia2Anna E. Ordo~nez, MD, Frances F. Loeb, BA, Xueping Zhou, MHS, Lorie Shora, MS,
Rebecca A. Berman, PhD, Diane D. Broadnax, MSW, Peter Gochman, MA,
Siyuan Liu, PhD, Judith L. Rapoport, MDObjective: Gender differences, including younger age of
onset and greater premorbid deﬁcits in men, have been
reported in adult-onset schizophrenia. This study compre-
hensively evaluated gender differences in childhood-onset
schizophrenia (COS), a rare variant of the disorder.
Method: Demographic, premorbid, clinical, familial, and
cognitive characteristics, presence of chromosomal ab-
normalities, and brain magnetic resonance imaging
cortical volumes were evaluated in 133 patients with COS.
Cortical analyses included age- and gender-matched
healthy volunteers (n ¼ 124).
Results: Males with COS (n ¼ 72) had a slightly but
signiﬁcantly younger age of onset than females with COS
(mean age 9.51 2.28 versus 10.29 1.63 years, t131¼ 2.21,
p¼ .03), higher verbal IQ scores (83.00 15.97 versus 75.58
 15.10, t89 ¼ 2.24, p ¼ .03), and higher rates of comorbid
pervasive developmental disorder (28.17% versus 6.90%,
c21 ¼ 9.54, p < .01) and attention-deﬁcit/hyperactivity
disorder (43.86% versus 21.43%, c21 ¼ 5.40, p ¼ .02).
There were no signiﬁcant gender differences across otherwww.jaacap.orgdemographic, IQ, or clinical measurements, frequency
of chromosomal abnormalities, family clinical measure-
ments, premorbid functioning, or in gender-by-disorder
interactions for magnetic resonance imaging brain
measurements.
Conclusion: The present comprehensive examination
found few remarkable gender differences inCOS.Although
less striking than that seen in adult-onset schizophrenia,
males with COS had a younger age of onset. Attention-
deﬁcit/hyperactivity disorder and pervasive develop-
mental disorder rates were high in COS overall, suggesting
greater neurodevelopmental vulnerability in COS. How-
ever, the gender ratios of these comorbidities in COSmirror
those of the general populations, indicating that these
gender differences might be unrelated to COS.
Key words: childhood-onset schizophrenia, gender dif-
ferences, cortical volumes
J Am Acad Child Adolesc Psychiatry 2016;55(9):792–799.ender differences in schizophrenia have been re-
ported for several aspects of the disorder.1,2 TheseG differences might contribute to the marked het-
erogeneity of disease presentation, course, and response to
treatment.3,4 Childhood-onset schizophrenia (COS), a rare,
severe, and possibly more homogenous variant of the
disorder,5,6 has not been comprehensively examined with
respect to gender differences.
Variations in the incidence and prevalence of schizo-
phrenia between men and women have been debated, with
some reports of increased incidence in men,7 whereas
epidemiologic studies have reported no difference in prev-
alence.8,9 The signiﬁcantly younger age of onset in men
(roughly 5–6 years earlier10,11) and a second peak of onset in
women older than 40 years might contribute to these re-
sults.3,10,11 Findings on gender differences in symptom pre-
sentation and prognosis are less consistent. Several studies
have found that women with schizophrenia have less severe
negative symptoms and better prognosis than men,2,12-14
whereas others have reported minimal to no gender differ-
ences.15,16 Because an earlier onset of schizophrenia tends to
relate to poorer prognosis,17 the later onset in women might
reﬂect some overall protective effect.
Deﬁcits in premorbid social functioning and cognitive
functioning in adult patients with schizophrenia,18 academicand occupational adjustment,19,20 marriage adjustment,18
and general premorbid functioning13,20 also tend to indi-
cate a mitigating effect for women. However, ﬁndings in
social functioning21-23 and cognitive functioning2,3 are less
conclusive. Moreover, although psychiatric comorbidities in
schizophrenia are common24,25 and can affect many of these
domains, salient differential effects of gender on frequency
of comorbidities in adult-onset schizophrenia appear lack-
ing. In COS, a previous study from this cohort identiﬁed
greater frequency of pervasive developmental disorder
(PDD) diagnoses in males with COS,26 and others have re-
ported greater comorbid attention-deﬁcit/hyperactivity
disorder (ADHD) in males with COS.25
Gender differences also have been reported in the brain
structure of patients with schizophrenia. Compared with
controls, patients with schizophrenia tend to have larger
total ventricular volume, smaller absolute whole brain vol-
ume, and smaller cerebral gray matter volume.27 Some re-
ports have indicated greater severity of these structural
abnormalities in men compared with women, especially
with regard to ventricular enlargement.28 However, the
ﬁndings are highly inconsistent,1,2 with some reporting that
women show greater decreases in the prefrontal cortex,
orbital regions, basal forebrain, anterior cingulate, and pos-
terior supramarginal gyrus, and others reporting greaterJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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LACK OF GENDER DIFFERENCES IN CHILDHOOD-ONSET SCHIZOPHRENIArelative decreases in fronto-medial and middle frontal
cortices, para-cingulate gyrus, and insula.29,30 Other studies
have found no gender differences with respect to abnor-
malities in volumes of cortical gray matter, white matter and
sulci, lateral and third ventricles, and key subcortical struc-
tures.31,32 This last point was highlighted in a meta-analysis
of 58 magnetic resonance imaging (MRI) studies of patients
with schizophrenia, which found that gender was not
signiﬁcantly related to structural differences.27
Few studies have examined gender differences in brain
development in early-onset schizophrenia (EOS) or COS. A
small longitudinal study (N ¼ 21) found that men with EOS
had more frontal gray matter loss compared with controls
than women with EOS, although that study was under-
powered to detect change in women owing to the small
sample size (23.81% women, n ¼ 5).33 Previous studies from
this cohort found no gender differences in cortical thickness
and subcortical volume development34,35 or development of
total cortical gray matter36 in patients with COS. Neverthe-
less, although changes in cortical brain volume are among
the most consistently reported abnormalities in adult-onset
schizophrenia and COS, a thorough and systematic evalua-
tion of potential gender differences remains lacking.37,38
The present study explored gender differences more
comprehensively in a larger sample of patients with COS.
Speciﬁcally, demographics, clinical presentation, premorbid
functioning, cognitive ability, presence of chromosomal ab-
normalities, brain MRI cortical volumes, and family clinical
data were examined. Because COS is in several respects
continuous with later-onset schizophrenia,39,40 the authors
expected that the more consistently reported genderTABLE 1 Demographic Data for Male and Female Patients With C
Variables
Males (54.14%) F
Mean  SD or n (%) n Mean 
Age at onset (y) 9.51  2.28 72 10.2
Race 72
Caucasian 41 (56.94) 33
African American 19 (26.39) 20
Asian 4 (5.56) 2
Other 8 (11.11) 5
Ethnicity 71
Hispanic 7 (9.86) 9
Non-Hispanic 64 (90.14) 51
Parental SES 71
1 13 (18.31) 9
2 24 (33.00) 17
3 18 (25.35) 23
4 16 (22.54) 8
5 0 (0.00) 3
IQ 53
Full IQ 79.02  16.20 74.6
Verbal IQ 83.00  15.97 75.5
Performance IQ 77.57  16.74 77.0
Note: Boldface type indicates statistical significance. Socioeconomic status (SES) was
5 ¼ lowest SES. SD ¼ standard deviation.
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younger age of onset in men, might be more prominent for
patients with COS.
METHOD
Participants
Patients were recruited as part of an ongoing longitudinal study of
COS at the National Institute of Mental Health (NIMH).41 Criteria
for selection and inclusion have been described previously.41,42
Brieﬂy, children and adolescents 6 to 18 years old who met DSM-
III-R/DSM-IV criteria for schizophrenia with onset before 13 years
of age and with a prepsychotic IQ above 70 were nationally
recruited. In total, 133 patients with COS (72 males and 61 females)
participated in the study. In addition, 124 age- and gender-matched
healthy volunteers formed the control group for analyses of brain
structure.
Clinical and Neuropsychological Measurements
A research team that included 2 psychiatrists collected the clinical
data of patients with COS, including a structured interview with the
patient and their parents at screening or admission.43 Interviews
included the Scale for the Assessment of Positive Symptoms,44 the
Scale for the Assessment of Negative Symptoms,45 the Brief Psy-
chiatric Rating Scale,46 the Simpson-Angus Extrapyramidal Side
Effect Scale,47 and the Abnormal Involuntary Movement Scale.48
Rates of comorbid ADHD were determined using the Schedule
for Affective Disorders and Schizophrenia (K-SADS).43 Because the
K-SADS does not include the PDD diagnosis, all children were
screened with the Autism Screening Questionnaire49 and further
assessed by clinical interview. Comorbid PDD was given when the
history and thorough review of clinical records showed clear PDD/
autistic spectrum symptoms before the onset of psychosis withhildhood-Onset Schizophrenia
emales (45.86%)
Test Statistic (df) p ValueSD or n (%) n
9  1.63 61 t131 [ 2.21 .03
60
(55.00) c23 ¼ 1.17 .76
(33.33)
(3.33)
(8.33)
60
(15.00) c21 ¼ 0.80 .37
(85.00)
60
(15.00) Fisher’s exact test ¼ 4 .13
(28.33)
(38.33)
(13.33)
(5.00)
38
6  16.33 t89 ¼ 1.26 .21
8  15.10 t89 [ 2.24 .03
5  18.30 t89 ¼ 0.14 .89
based on a 2-factor index of social position by Hollingshead65: 1 ¼ highest SES,
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FIGURE 1 Age of onset of childhood-onset schizophrenia.
ORD O ~NEZ et al.symptoms still observable at the NIMH evaluation (see Sporn et al.26
for more details). During an extensive clinical evaluation, parents of
the participants with COS reported age of onset and premorbid
developmental, academic, social, language, and motor problems or
delays and provided corresponding medical and school records.
These were combined into a “Hollis score” according to the pre-
morbid developmental difﬁculties described previously.50
In addition, trained study staff administered the current age-
appropriate versions of Wechsler Intelligence Scales to participants
with COS at baseline or follow-up. Because participants had varying
degrees of psychotic symptoms at different time points, which
affected their ability to engage in IQ testing, for participants who
had IQ testing at baseline and follow-up, the highest score was
selected. The Wechsler Adult Intelligence Scale–Revised51 and the
Wechsler Abbreviated Scale of Intelligence First Edition52 and Sec-
ond Edition53 were versions used along with the Wechsler Intelli-
gence Scale for Children–Revised54 and Third Edition.55
Biological parents and full siblings of participants with COS
were evaluated with clinical and structural diagnostic interviews
(details reported previously26) to assess the presence or history of a
DSM-IV diagnosis and presence or symptom counts of paranoid
personality disorder, schizoid personality disorder, schizotypal
personality disorder, and avoidant personality disorder.
Genetic Measurements
As part of a broader study of the genetics of EOS, DNA was ob-
tained from all participants with COS. Chromosome abnormalities
in the participants with COS were determined from array-based
single-nucleotide polymorphism genotyping from blood samples
and is described elsewhere.56 In the present study, carrier status (yes
versus no) of chromosome abnormalities, including copy number
variants and large chromosomal errors, were compared in males
and females.
Image Acquisition and Processing
T1-weighted images were acquired with the same 1.5-T MRI scanner
(Signa; GE Medical Systems, Milwaukee, WI). A 3-dimensional
spoiled gradient-recalled echo in the steady-state sequence
designed to optimize discrimination of gray matter, white matter,
and cerebrospinal ﬂuid was used to acquire 124 contiguous 1.5-mm-
thick sections in the axial plane (repetition time 24 ms, echo time
5 ms, ﬂip angle 45, acquisition matrix 256  192, ﬁeld of view
24 cm). Each participant was scanned at approximately 2-year
intervals.
Freesurfer 5.3 (http://surfer.nmr.mgh.harvard.edu/fswiki) was
used for surface-based cortical processing57,58 and volumetric
subcortical segmentation59 of T1-weighted anatomic images. All794 www.jaacap.orgindividual images were transformed into Talairach space.60 Based
on prior probabilistic information, parcellation of each cortical
hemispheric sheet into 34 regions was performed.61,62 A trained im-
aging specialist reviewed individual scans, and those with signiﬁcant
artifact or motion disturbance were excluded from analysis. In total,
287 scans of patients with COS (60males and 45 females) and 360 scans
of healthy matched control participants (72 males and 52 females)
were included in the ﬁnal analysis. Volumes of each cortical and
subcortical region were extracted. Total cortical volumewas calculated
as the sum of all 34 cortical regions in the left and right hemispheres
without including the cerebrum and subcortical gray matter. Esti-
mated total intracranial volume (ICV) was used as the ICV.63
Statistical Analysis
Demographic and Clinical Data. Independent t tests were used to
determine signiﬁcant differences between males and females with
COS for continuous demographic, clinical, and neuropsychological
variables. A c2 test or Fisher exact test was used to assess the sig-
niﬁcance of the differences in categorical variables. Missing data
were excluded pairwise from the analyses. A p value less than .05 (2-
tailed) was considered statistically signiﬁcant. Bonferroni correction
for multiple comparisons was used for imaging data but not for the
clinical and demographic variables because of numerous in-
consistencies in gender differences on these dimensions in adult
schizophrenia and the exploratory nature of these analyses in the
present COS sample. As Streiner and Norman64 suggested, cor-
recting for multiplicity in these situations results in an excess of type
II errors, closing off potentially worthwhile research areas. All de-
mographic, clinical, and neurobiological analyses were done using
STATA/SE 14.0 statistical software (Stata Corp, College Station, TX),
and all brain imaging analyses were carried out in the Statistics
Toolbox of MathLab R2014A (The Math Works, Inc., Natick, MA).
Brain Differences Between Groups in Each Gender. In the cross-
sectional analysis, analysis of variance models were used to
examine group differences in volume measurements for males and
females separately when the ﬁrst MRI scan was collected. Each
volume measurement was inputted as the dependent variable, and
group was inputted as the independent variable. Total cortical vol-
ume, total ventricular volume, and 34 cortical region volumes were
examined in each hemisphere. ICV was used as a covariate variable
for the correction of head size when examining individual cortical
regions. For each volume measurement, Cohen’s d was calculated as
the effect size of group difference for males and females.
Interaction Effect Between Gender and Group on Brain Vol-
umes. Analysis of variance models were used to examine further the
interaction effect between gender (males versus females) and group
(COS versus control). Each volume measurement was inputted as
the dependent variable, and gender and group were inputted as
independent variables that interact with each other. ICV was used as
a covariate variable. The signiﬁcant threshold of p was set at .00071
for Bonferroni correction of a total of 70 comparisons.
In parallel to the cross-sectional analysis, all scans were used to
perform longitudinal analysis with linear mixed effect models to
examine group differences in brain volume development for all re-
gions. Brain volume was the dependent variable. Fixed effects
included group, gender, age (centered at the average age of 17.00),
an interaction term of gender by group, and ICV. A random inter-
cept per person was included to account for within-subject variance.
RESULTS
Gender differences were examined across several domains in
133 patients with COS (46% females). For the IQ analysis, 42
participants (19 males and 23 females) were unable orJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TABLE 2 Clinical Ratings for Male and Female Patients With Childhood-Onset Schizophrenia
Variables
Males (54.14%) Females (45.86%)
Test Statistic (df) p ValueMean  SD or n (%) n Mean  SD or n (%) n
ASQ score 9.49  8.35 69 8.26  8.39 54 t121 ¼ 0.81 .42
Hollis score 4.17  2.90 72 3.35  2.76 60 t130 ¼ 1.65 .10
SAPS score 37.24  18.64 62 41.40  17.51 53 t113 ¼ 1.22 .22
SANS score 47.81  27.52 62 56.36  23.84 55 t115 ¼ 1.79 .08
BPRS score 46.99  13.11 68 47.66  12.64 58 t124 ¼ 0.29 .77
SIM score 11.96  2.74 48 15.31  14.82 49 t95 ¼ 1.54 .13
AIMS score 10.98  2.09 44 10.69  2.46 45 t87 ¼ 0.60 .55
PDD 20 (28.17) 71 4 (6.90) 58 c21 [ 9.54 <.01
ADHD 25 (43.86) 57 9 (21.43) 42 c21 [ 5.40 .02
Abnormal chromosome 16 (22.22) 72 20 (32.79) 61 c21 ¼ 1.87 .17
Note: Boldface type indicates statistical significance. ADHD ¼ attention-deficit/hyperactivity disorder; AIMS ¼ Abnormal Involuntary Movement Scale; ASQ ¼ Autism
Screening Questionnaire; BPRS ¼ Brief Psychiatric Rating Scale for Children 18 Symptoms Version; PDD ¼ pervasive developmental disorder; SANS ¼ Scale for the
Assessment of Negative Symptoms; SAPS ¼ Scale for the Assessment of Positive Symptoms; SD ¼ standard deviation; SIM ¼ Simpson-Angus Extrapyramidal Side
Effect Scale.
LACK OF GENDER DIFFERENCES IN CHILDHOOD-ONSET SCHIZOPHRENIAunwilling to engage in IQ testing at any time point; therewere
no gender differences between the tested anduntested groups
(c2 ¼ 2.0, p ¼ .16). There were no signiﬁcant gender differ-
ences among race, ethnicity, parental socioeconomic status,
or full-scale IQ (Table 1). There also were no signiﬁcant
gender differences in the version of the IQ test administered
(c2 ¼ 10.50, p ¼ .11) or the age at IQ test (t ¼ 0.95, p ¼ .11).
However, females with COS had signiﬁcantly lower ver-
bal IQ than males with COS (t89 ¼ 2.24, p ¼ .03). In addition,
males had a slightly but signiﬁcantly younger age of onset
than females in the sample (t131 ¼ 2.21, p ¼ .03). There was
greater density of younger ages of onset in males compared
with females (Figure 1). Clinical review of the charts of
younger males did not show any striking clinical differences
from the males with later-onset COS. There were no signiﬁ-
cant differences between males and females in chromosomal
abnormalities or in most clinical measurements (Table 2).
Most chromosomal abnormalities were distinct cases of copy
number variants, with 3 cases of 2 patients with COS having
the same copy number variant (2q25.3, 15q13.3 deletion,
16p11.2 duplication) and 5 patients with COS with 22q11.21
deletion, as reported previously.56 However, males had
signiﬁcantly higher rates of comorbid PDD (c21 ¼ 9.54, p <
.01) and ADHD (c21 ¼ 5.40, p ¼ .02) than females. Males and
females did not signiﬁcantly differ in rates of premorbid ab-
normalities across academic, language, and motor domains.
In the social domain, 55 of 71 males (76.4%) and 35 of 58 fe-
males (58.3%) reported premorbid social abnormalities (c21¼
4.92, p ¼ .03). Nonetheless, further analysis showed that the
presence of PDD, which was higher in males, accounted for
this difference. In patients with COS without a PDD diag-
nosis, 35 of 51 males (68.6%) and 31 of 54 females (57.4%)
reported premorbid social abnormalities (c21 ¼ 1.41, p ¼ .23).
There were no gender differences in the presence of
schizophrenia, schizoaffective disorder, bipolar disorder,
psychosis, mood disorders, anxiety disorders, alcohol dis-
orders, and behavioral disorders in mothers, fathers, sib-
lings, and family members independently (data not shown).JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 55 NUMBER 9 SEPTEMBER 2016Similarly, there were no differences in the presence or
number of symptoms of paranoid personality disorder,
schizoid personality disorders, schizotypal personality dis-
order, and avoidant personality disorder.
A cross-sectional analysis of baseline images at the
average age of 14.24 years examined gender differences in
brain structural abnormalities. Total ventricular volume was
signiﬁcantly larger and total cortical volume was signiﬁ-
cantly smaller in participants with COS than in control
participants for males and females (Table 3), but no signiﬁ-
cant interactions were found between gender and group.
Effect sizes were similar between males and females, indi-
cating that abnormalities in the overall brain structure did
not differ between genders.
In addition to these 2 global measurements, 34 cortical
regions in each hemisphere were examined, and several
areas showed a trend (p < .1) toward an interaction effect.
Speciﬁcally, males with COS had more volume loss than
females in the left lateral orbitofrontal, caudal anterior
cingulate, and fusiform cortices (Table 3). However, no sig-
niﬁcant group-by-gender interaction effects were found in
global or regional cortical volumes.
A longitudinal analysis further examined gender differ-
ences in brain volume development (not shown). In total,
647 scans (287 from 105 patients with COS at the average age
of 17.00 years, 360 from 124 controls at the average age of
16.42 years) were included. There were no signiﬁcant dif-
ferences in mean age at scan or number of scans per
participant between the COS and control groups (data not
shown). No signiﬁcant interactions between gender and
group were found for global and individual regional vol-
umes (data available on request).DISCUSSION
After an extensive examination of gender differences in pa-
tients with COS, including global and regional cortical vol-
umes, presence of chromosomal abnormalities, numerouswww.jaacap.org 795
TABLE 3 Cross-Sectional Regional Brain Volumes for Male and Female Patients With Childhood-Onset Schizophrenia (COS) and Healthy Matched Control (HC)
Participants
Volume (mL)
Males Females
Gender  Group
Interactionb
COS HC COS vs. HC Effect Size COS HC COS vs. HC Effect Size
Males (COS vs. HC)
vs. Females
(COS vs. HC)
Mean  SD Mean  SD p Value Cohen’s d Mean  SD Mean  SD p Value Cohen’s d p Value
Global measurement
Total ventricles 19.54  10.40 13.54  7.59 .00018 0.67 16.0  7.2 11.7  6.1 .00025 0.66 .57
Total cortex 514.59  72.26 563.89  47.46 .000000083 0.82 450.1  46.2 497.2  36.5 .000000069 1.14 .56
Individual cortical regiona
Effect size (males <
females)
Left primary auditory
cortex
1.28  0.27 1.34  2.62 .15 0.23 1.02  0.21 1.22  0.20 .0000073 0.98 .04
Right primary
auditory cortex
0.97  0.18 1.04  0.20 .039 0.35 0.81  0.17 0.97  0.17 .000024 0.92 .08
Effect size (males >
females)
Left caudal anterior
cingulate cortex
1.83  0.47 2.17  0.53 .000081 0.67 1.75  0.44 1.89  0.47 .17 0.31 .08
Left fusiform 9.83  1.91 11.14  1.65 .0000016 0.74 8.81  1.44 9.52  1.24 .014 0.53 .06
Left lateral orbitofrontal
cortex
7.86  1.38 8.72  1.11 .000016 0.70 7.17  1.10 7.66  0.78 .017 0.52 .10
Note: Boldface type indicates statistical significance. SD ¼ standard deviation.
aOnly individual cortical regions with a p value of interaction effect (whether using intracranial volume as a covariate or not) less than .1 were included here.
bNo significant interaction effect was found for global measurements and individual cortical regions (p < .00071 for Bonferroni correction).
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LACK OF GENDER DIFFERENCES IN CHILDHOOD-ONSET SCHIZOPHRENIAclinical ratings, family clinical ratings, abnormalities in pre-
morbid functioning, and demographic variables, the only
gender differences found in this study were a slightly but
signiﬁcantly younger age of onset and higher comorbid
ADHD and PDD diagnoses in males and lower verbal IQ in
females. Consistent with the approximate 4:1 ratio of PDD in
the general population,66,67 males in the present sample were
4 times more likely to have PDD than females. Similarly, the
2:1 male-to-female ratio of ADHD in the present sample
matched that found in the general population.68 Because
these ratios mirror those of the non-COS population, these
gender differences are likely unrelated to the presentation
of COS and instead reﬂect general gender differences.
However, it is noteworthy that both of these comorbidities
were much more prevalent in the present COS sample than
seen in the population at large. Higher prevalence of lifetime
ADHD in COS also was observed in the study of Ross
et al.,25 who reported lifetime rates of comorbid ADHD in 16
of 23 females (70%) and 54 of 60 males (90%) with COS
(gender effect, p ¼ .03). These ﬁndings support a more
general model of greater neurodevelopmental vulnerability
underlying COS.69-71
In addition, in keeping with studies of adult schizo-
phrenia,10 males had a signiﬁcantly younger age of onset
than females. Although the mean age of onset was less than
a year different between males and females (Figure 1), 11 of
the 12 youngest onset cases were males. However, after in-
dividual review of clinical records in this subgroup, no
clinical correlates for age of onset were found in this group.
This ﬁnding remains unexplained and will beneﬁt from
future work with careful attention to possible causes or
correlates of this apparent early difference.
No gender-by-group interactions were found for brain
MRI measurement at baseline or longitudinally. This is
consistent with the authors’ previous ﬁndings, which indi-
cated no gender differences in cortical thickness, subcortical
volume development,34,35 or cortical gray matter develop-
ment.36 These ﬁndings also corroborate the ﬁndings of
studies on adult-onset schizophrenia.27 Although the
numbers of studies assessing gender differences in EOS and
COS are few overall, contrary to the present ﬁnding, a small
longitudinal study found that men with EOS have more
frontal gray matter loss compared with controls than
women. However, the study was limited by a small sample
of women (n ¼ 5; total N ¼ 21) and lacked analysis of the
gender-by-group interaction.33
From a clinical perspective, the common ﬁnding that
women have better premorbid functioning than men in
adult schizophrenia does not hold in the present COS sam-
ple, nor does the less-consistent ﬁnding that women have
less severe negative symptoms.12-14 The present study found
no signiﬁcant gender difference in any clinical measure-
ments or in social, academic, motor, and language pre-
morbid functioning after accounting for PDD.
Interestingly, females in the present sample also scored
lower on verbal IQ than males, but there was no signiﬁcant
difference in overall or performance IQ. Cognitive func-
tioning is one of the most inconsistently reported genderJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 55 NUMBER 9 SEPTEMBER 2016differences in the adult schizophrenia literature, with many
studies ﬁnding no differences.72-75 For example, Bozikas
et al.76 found that women with schizophrenia have better
verbal learning and memory than men with schizophrenia.
However, Lewine et al.77 found that women with schizo-
phrenia score lower in the language domain, consisting of
verbal IQ and oral ﬂuency, than men, in line with the present
ﬁnding. Overall, the present ﬁndings suggest that in COS,
patients’ IQ tends to be similar for males and females.
Limitations of this study included the inevitable unknown
referral and selection biases when recruiting for a very rare
disorder. Although the authors recruited nationally, this is
not a population-based sample. In addition, because males
had signiﬁcantly higher rates of ADHD and PDD, the ﬁnding
of a younger age of onset might be associated with a younger
age of contact with mental health professionals. Another
limitation is that all participants were taking antipsychotic
medications at the time of their MRI scan, which could affect
the present ﬁndings; however, because females and males
were taking medications, it seems unlikely that these would
affect the ﬁndings differentially. Furthermore, because some
studies have associated exposure to typical78 or atypical79,80
antipsychotics with increased basal ganglia and other
subcortical gray matter volumes, subcortical gray matter
volumes were not examined to avoid this confounding effect.
Although the present numbers are small, the study represents
the largest study to date of patients with COS.
In conclusion, after a thorough review of premorbid,
clinical, familial, cognitive, and structural imaging, this
study found few remarkable gender differences in COS.
Furthermore, the strongest ﬁnding of greater comorbid PDD
and ADHD in males replicates the gender ratio observed in
the general population and is unlikely to be speciﬁc to COS-
related gender differences. Although this study did not
assess genetic data in depth, there were no signiﬁcant or
clinically meaningful gender differences in COS. &Accepted June 23, 2016.
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